EAH
NEUTRALECO Animal Health Receives EU Approval for ECOVAXXIN® MS Poultry Vaccine
The healthcare company has received EU approval for its new poultry vaccine, a key milestone for the business.
ECO Animal Health Group
114.00GBX
5.07%
Market Cap
76.94M
Volume
147.08k
207% of avg
P/E Ratio
4169.71
EPS (TTM)
0.03
Beta
-0.01
Day Range
109.94p - 116.90p
52 Week Range
50.00p114.00p116.90p
114.00p
Upcoming Events
EAH
NEUTRALECO Animal Health Director Exercises Share Options
The retailer announces a director has exercised share options, a standard corporate action.
EAH
NEUTRALEco Animal Health Group Announces Holding Change
The healthcare company has announced a change in major shareholding, with Schroders PLC now holding 18.95% of the shares.
EAH
NEUTRALECO Animal Health Director Increases Shareholding
The CEO of the animal health company has purchased additional shares, signaling confidence in the business.
EAH
NEUTRALECO Animal Health Reports Revenue Growth and Margin Improvement in H1 2025
The animal health company reported a 19% revenue increase and improved gross margins, despite ongoing market headwinds. Progress in vaccine development shows promise for future growth.
EAH
NEUTRALECO Animal Health Group Announces Interim Results Date
The animal health company announces the date for its interim results presentation and investor webcast.
EAH
NEUTRALECO Animal Health Group Announces Upcoming Results and Investor Presentation
The animal health company announces plans to release its interim results and host an investor presentation.
EAH
NEUTRALECO Animal Health Receives Positive EMA Opinion for ECOVAXXIN® MS Vaccine
The healthcare company received a positive opinion from the European Medicines Agency for its ECOVAXXIN® MS poultry vaccine, paving the way for a commercial launch in the EU in the second half of 2026.
EAH
NEUTRALECO Animal Health Announces Head of Global R&D Departure
The healthcare company announces the departure of its Head of Global R&D, with the search for a replacement underway.
EAH
VERY GOODECO Animal Health Delivers Strong First Half Performance
The healthcare company reports a robust first half, with revenue growth exceeding 15% and improved profitability.